Prolongation of PR interval may increase risk of heart rhythm disturbances, more study needed.
A common electrocardiogram (ECG) finding that has largely been considered insignificant may actually signal an increased risk of atrial fibrillation (a chronic heart rhythm disturbance), the future need for a permanent pacemaker and an increased risk for premature death. In their report in the June 24 Journal of the American Medical Association, researchers from Massachusetts General Hospital (MGH) and Boston University School of Medicine describe results of the first large-scale study looking at the significance of a prolonged PR interval in a general population.
"Lengthening of the PR interval is commonly seen on routine electrocardiograms, more often in older patients, and has been considered a relatively harmless finding," says Susan Cheng, MD, a cardiology fellow at MGH and Brigham and Women’s Hospital who is lead author of the JAMA paper. "But our results indicate that PR interval prolongation is not as benign as previously thought."
A common diagnostic test available in most physicians’'offices, the electrocardiogram records the heart' electrical activity and translates it into waveforms that reflect how the contraction signal moves through the heart muscle. A prolonged PR interval represents a delay in the time it takes for the signal to move across the atria at the top of the heart, which receive blood flowing in from the veins, into the ventricles at the bottom of the heart, which pump blood out into the arteries. Although a prolonged PR interval can signify conduction problems related to serious conditions such as a heart attack, a prolonged PR interval is most commonly seen in generally healthy, middle-aged to older adults and has been thought to reflect normal age-related changes. But previous investigations of the impact of PR prolongation were limited to younger, healthy participants, such as members of the military.
The current study analyzed data from more than 7,500 participants in the Framingham Heart Study, followed for more than three decades. Although only 124 of those participants showed a prolonged PR interval on the electrocardiogram taken when they entered the study, PR prolongation proved to be a significant risk factor. A PR interval of less than 200 milliseconds is considered normal, and participants whose interval was longer than 200 milliseconds had twice the overall risk of developing atrial fibrillation, three times the risk of needing a pacemaker and almost one and a half times the risk of early death. Further prolongation of the PR interval led to even greater risk.
"We do not yet know why a subtle finding such as a prolonged PR interval is associated with such serious adverse outcomes, but it may be a marker for progressive problems with the heart’s electrical conduction system," says Thomas Wang, MD, of the MGH Heart Center, the study’s senior author. "We need to learn more about how a prolonged PR interval is linked to these serious events and what should be done to prevent them. Right now, clinicians might consider that their patients with PR prolongation may be at increased risk of these problems and follow their electrocardiograms more closely." Wang is an assistant professor of Medicine at Harvard Medical School.
Co-authors of the JAMA report are Elizabeth McCabe, MS, and Christopher Newton-Cheh, MD, MPH, MGH Cardiology; Michelle Keyes, PhD, Martin Larson, ScD, Daniel Levy, MD, Emelia Benjamin, MD, ScM, and Ramachandran Vasan, MD, Boston University School of Medicine. The Framingham Heart Study is supported jointly by the National Heart, Lung and Blood Institute and Boston University.
Massachusetts General Hospital, established in 1811, is the original and largest teaching hospital of Harvard Medical School. The MGH conducts the largest hospital-based research program in the United States, with an annual research budget of more than $500 million and major research centers in AIDS, cardiovascular research, cancer, computational and integrative biology, cutaneous biology, human genetics, medical imaging, neurodegenerative disorders, regenerative medicine, systems biology, transplantation biology and photomedicine.
Contact: Jennifer Gundersen, 617 724-6433, firstname.lastname@example.org
Source: Massachusetts General Hospital